Serum Vascular Endothelial Growth Factor in Egyptian Obese Women with Insulin Resistance

Moushira Erfan Zaki; Walaa Basha; Rasha Nazih Yousef; Mona Awad

doi:10.3889/oamjms.2019.156

Authors

Moushira Erfan Zaki Biological Anthropology Department, Medical Research Division, National Research Centre, Cairo, Egypt
Walaa Basha Biological Anthropology Department, Medical Research Division, National Research Centre, Cairo, Egypt
Rasha Nazih Yousef Clinical & Chemical Pathology, Medical Research Division, National Research Centre, Cairo, Egypt
Mona Awad Clinical & Chemical Pathology, Medical Research Division, National Research Centre, Cairo, Egypt

DOI:

https://doi.org/10.3889/oamjms.2019.156

Keywords:

Vascular Endothelial Growth Factor, Insulin resistance, Obesity, Metabolic profile, Serum lipids

Abstract

BACKGROUND: Obesity is a major factor in the development of several sub-clinical anomalies. Insulin resistance (IR) is associated with obesity. Vascular endothelial growth factor (VEGF) plays a significant role in inflammation and vascular neogenesis. However the precise relationships of its levels with clinical, lipid, and metabolic profiles are unknown.

AIM: This study aimed to examine the association between serum VEGF concentrations with IR risk and metabolic and lipid parameters in obese women.

METHODS: Serum VEGF, metabolic biomarkers and anthropometry were measured in 83 obese women with IR and 50 healthy women. Fat distributions in the abdominal, subcutaneous and visceral area were assessed. Homeostasis model assessment for insulin resistance index (HOMA-IR) was calculated. For analytical purposes, VEGF levels were categorised into three tertiles groups.

RESULTS: Obese women with IR showed significantly higher levels of serum VEGF as compared with the control group. Moreover, obese women in the highest VEGF tertile had significantly higher values of obesity indices, visceral fat index, abnormal lipid levels and HOMA-IR compared to with those in the lower tertile.

CONCLUSION: Elevated VEGF levels are associated with IR and high visceral fat index in obese women which in turn increased the risk for metabolic complications.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

GroÃŸschÃ¤dl F, Stronegger WJ. Regional trends in obesity and overweight among Austrian adults between 1973 and 2007. Wien Klin Wochenschr. 2012; 124(11-12):363-9. https://doi.org/10.1007/s00508-012-0175-4

Debette S, Visvikis-Siest S, Chen MH, Ndiaye NC, Song C, Destefano A, et al. Identification of cis-and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels. Circ Res. 2011; 109(5):554-63. https://doi.org/10.1161/CIRCRESAHA.111.243790 PMid:21757650 PMCid:PMC3193930

Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007; 56(4):901-11. https://doi.org/10.2337/db06-0911 PMid:17395738

Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, et al. Reduced adipose tissue oxygenation in human obesity. Diabetes. 2009; 58(3):718-25. https://doi.org/10.2337/db08-1098 PMid:19074987 PMCid:PMC2646071

Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem. 2008; 114(4):267-76. https://doi.org/10.1080/13813450802306602 PMid:18946787

Soverini V, Moscatiello S, Villanova N, Ragni E, Di Domizio S, Marchesini G. Metabolic syndrome and insulin resistance in subjects with morbid obesity. Obes Surg. 2010; 20(3):295-301. https://doi.org/10.1007/s11695-009-9999-z PMid:19841991

BlÃ¼her M. The distinction of metabolically "healthy" from "unhealthy" obese individuals. Curr Opin Lipidol. 2010; 21(1):38-43. https://doi.org/10.1097/MOL.0b013e3283346ccc PMid:19915462

Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci. 2004; 82:925-34. https://doi.org/10.1093/ansci/82.3.925

Barratt SL, Flower VA, Pauling JD, Millar AB. VEGF ( Vascular Endothelial Growth Factor ) and Fibrotic Lung Disease. 2018. https://doi.org/10.3390/ijms19051269

King GL, Park K, Li Q. Selective insulin resistance and the development of cardiovascular diseases in diabetes: The 2015 Edwin Bierman Award Lecture. Diabetes. 2016; 65(6):1462-71. https://doi.org/10.2337/db16-0152 PMid:27222390 PMCid:PMC4878431

Tinahones F, CoÃn-AragÃ¼ez L, Mayas M, Garcia-Fuentes E, Hurtado-del-Pozo C, Vendrell J, et al. Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol. 2012; 12(1):4. https://doi.org/10.1186/1472-6793-12-4 PMid:22471305 PMCid:PMC3382430

Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009; 21(2):154-65. https://doi.org/10.1016/j.ceb.2008.12.012 PMid:19230644

Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci. 2004; 82(3):925-34. https://doi.org/10.1093/ansci/82.3.925

Silha J V, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes. 2005; 29(11):1308-14. https://doi.org/10.1038/sj.ijo.0802987 PMid:15953938

Loebig M, Klement J, Schmoller A, Betz S, Heuck N, Schweiger U, et al. Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS One. 2010; 5(9):e12610. https://doi.org/10.1371/journal.pone.0012610

Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch JR, et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis. 2009; 206(1):265-9. https://doi.org/10.1016/j.atherosclerosis.2009.01.031 PMid:19237157

Zaki M, Kamal S, Ezzat W, Hassan N, Yousef W, Ryad H, et al. Serum apelin levels and metabolic risk markers in obese women. J Genet Eng Biotechnol. 2017; 15(2). https://doi.org/10.1016/j.jgeb.2017.05.002

Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000; 72(3):694-701. https://doi.org/10.1093/ajcn/72.3.694 PMid:10966886

Friedewald WT, Levy RI, Fredrickson DS. William T. Friedewald.pdf. Clin Chem. 1972; 18(6):499-502.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and Î²-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. https://doi.org/10.1007/BF00280883 PMid:3899825

Stephan CC, Brock TA. Vascular endothelial growth factor, a multifunctional polypeptide. P R Health Sci J. 1996; 15(3):169-78.

Roy H, Bhardwaj S, YlÃ¤-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 2006; 580(12):2879-87. https://doi.org/10.1016/j.febslet.2006.03.087 PMid:16631753

Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia. 2007; 50(4):747-51. https://doi.org/10.1007/s00125-006-0588-6 PMid:17245589

Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia. 2003; 46(11):1483-8. https://doi.org/10.1007/s00125-003-1221-6 PMid:14534780

Pinkney JH, Stehouwer CDA, Coppack SW, Yudkin JS. Endothelial dysfunction: Cause of the insulin resistance syndrome. Diabetes. 1997; 46(SUPPL. 2). https://doi.org/10.2337/diab.46.2.S9

Wei Y, Liu GL, Yang JY, Zheng RX, Jiang LH, Li YP, et al. Association between metabolic syndrome and vascular endothelium dysfunction in children and adolescents. Genet Mol Res. 2014; 13(4):8671-8. https://doi.org/10.4238/2014.October.27.7 PMid:25366757

CÃ©be-Suarez S, Zehnder-FjÃ¤llman A, Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell Mol Life Sci. 2006; 63(5):601-15. https://doi.org/10.1007/s00018-005-5426-3 PMid:16465447 PMCid:PMC2773843

Elias I, Franckhauser S, Bosch F. New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance. Adipocyte. 2013; 2(2):109-12. https://doi.org/10.4161/adip.22880 PMid:23805408 PMCid:PMC3661112

Elias I, Franckhauser S, FerrÃ© T, VilÃ L, Tafuro S, Mu-oz S, et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes. 2012; 61(7):1801-13. https://doi.org/10.2337/db11-0832 PMid:22522611 PMCid:PMC3379662

Lu X, Ji Y, Zhang L, Zhang Y, Zhang S, An Y, et al. Resistance to Obesity by Repression of VEGF Gene Expression through Induction of Brown-Like Adipocyte Differentiation. Endocrinology. 2012; 153(7):3123-32. https://doi.org/10.1210/en.2012-1151 PMid:22593269

Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, et al. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis. 2010; 208(2):512-7. https://doi.org/10.1016/j.atherosclerosis.2009.07.045 PMid:19695569

Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res. 2007; 100(6):769-81. https://doi.org/10.1161/01.RES.0000259589.34348.74 PMid:17395883

Singh K, Sandler S, Espes D. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control. 2017; 2017. https://doi.org/10.1155/2017/6192896

Erman H, Gelisgen R, Cengiz M, Tabak O, Erdenen F, Uzun H. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome. 2016; 20:1015-22.